You can see why leukemia/lymphomas are always divided into the Hodgkins category or the non-hodgkins lymphomas (NHLs). In the NHLs, the abundant tumor lymphocytes are the malignancy. In HD, the bulk of the nodules are normal lymphocytes and inflammatory cells, proliferating under the signaling coming from the rare malignant RS cells. That is so cool to appreciate. And interrupting the positive feedback loop that creates the tumor microenvironment will lead to the death of the RS cells. Cure!
When I was a medical student, I just learned the differences between Hodgkin and nonHodgkin lymphoma. I really enjoyed delving into the pathophysiology of this fascinating tumor for this video!
That was an excellent presentation. On point and clear!
Thank you! It is such a fascinating disease from a pathophysiologic point of view!
You can see why leukemia/lymphomas are always divided into the Hodgkins category or the non-hodgkins lymphomas (NHLs). In the NHLs, the abundant tumor lymphocytes are the malignancy. In HD, the bulk of the nodules are normal lymphocytes and inflammatory cells, proliferating under the signaling coming from the rare malignant RS cells. That is so cool to appreciate. And interrupting the positive feedback loop that creates the tumor microenvironment will lead to the death of the RS cells. Cure!
When I was a medical student, I just learned the differences between Hodgkin and nonHodgkin lymphoma. I really enjoyed delving into the pathophysiology of this fascinating tumor for this video!